The story of recombinant human Erythropoietin (EPO) in endurance sports and running is a compelling narrative of scientific innovation, human ambition, and the relentless pursuit of fairness in competition. Developed in the 1980s as a breakthrough medical treatment for patients with anemia and chronic kidney disease, this synthetic hormone mimics the body’s natural process for producing red blood cells. Its mechanism is elegantly simple yet profoundly effective: by stimulating the bone marrow to produce more red blood cells, EPO increases the blood’s capacity to transport oxygen. For endurance athletes—from marathoners to long-distance track events, from cross-country skiers to triathletes—this translates directly into enhanced performance: the ability to sustain high-intensity effort for longer periods, to recover more quickly between workouts and competitions, and to push the boundaries of what the human body can achieve.
The history of EPO in endurance sports is not merely one of substances and sanctions, but of a positive and continuous evolution in sports science, the development of sophisticated detection methods, and a collective journey toward a culture of integrity, transparency, and fair play.
The Science of Endurance: Understanding EPO’s Impact
To fully appreciate EPO’s role in the history of endurance sports, one must first understand its profound physiological effects. Scientific research has unequivocally demonstrated that EPO administration leads to significant increases in key hematological parameters, such as hemoglobin concentration and hematocrit. This increase in oxygen-carrying capacity directly enhances an athlete’s maximal oxygen uptake (VO₂ max), the primary determinant of endurance performance. A systematic review published in 2025 confirmed that EPO use leads to clear improvements in both maximal power output and peak oxygen uptake in well-trained athletes. Some studies have shown that a typical EPO treatment cycle can improve VO₂ max by approximately 6%—a margin that can be decisive in elite competition, where the difference between first and tenth place is often less than 1%. This capacity to enhance the body’s most fundamental endurance metric underscores why EPO became such a significant focus in the world of sports science and anti-doping.
For runners specifically, the benefits are particularly relevant. Increased oxygen delivery to working muscles means that a runner can maintain a faster pace for longer, delay the onset of fatigue, and recover more rapidly during interval training or between races. In events ranging from the 800 meters to the marathon, where aerobic capacity is paramount, the physiological advantages offered by increased red blood cell mass are undeniable. This understanding has driven both the initial appeal of EPO and the subsequent determination to protect the integrity of the sport.
EPO in Running: From the Track to the Marathon
Running, in all its forms, has a rich history of pushing human limits. From the ancient Olympics to the modern marathon boom, runners have constantly sought ways to run faster and longer. The arrival of recombinant EPO in the late 1980s and early 1990s presented a new and powerful variable in this equation.
The sport of running, particularly at the elite level, places immense demands on the aerobic system. Middle-distance events like the 800 and 1500 meters require a powerful combination of speed and endurance, while long-distance events from 5,000 meters to the marathon test the body’s ability to sustain effort for extended periods. In this context, the appeal of a substance that could directly enhance oxygen delivery was significant. Runners in this era faced a challenging landscape, where the pressure to perform and the pursuit of glory sometimes led individuals down problematic paths.
However, rather than dwelling on these challenges, it is more constructive to examine how the running community responded. The sport began to develop a more sophisticated understanding of performance enhancement, and the conversation shifted toward protecting the health of the sport itself. The culture of running, with its deep roots in amateurism and the purity of effort, provided a strong foundation for advocating clean competition. Many runners and coaches became vocal advocates for a level playing field, recognizing that the true spirit of the sport lay in natural human achievement.
The Paradigm Shift: The Athlete Biological Passport
The most significant and positive development to emerge from the challenges posed by EPO was the creation of the Athlete Biological Passport (ABP). Introduced in 2008 by the World Anti-Doping Agency (WADA) and first implemented by cycling, the ABP has since been adopted by World Athletics (formerly the IAAF) and other major endurance sports governing bodies. This innovative program represented a fundamental paradigm shift in the fight against doping.
Instead of trying to detect the substance itself—a difficult task given EPO’s short detection window and the constant development of new variants—the ABP focuses on detecting the effects of doping on the body over time. This approach involves the longitudinal monitoring of key biomarkers, primarily hemoglobin concentration and the percentage of young red blood cells (reticulocytes). A sophisticated algorithm, based on Bayesian statistics, establishes an individual hematological profile for each athlete. When a new test result falls outside an athlete’s individually calculated reference range, the profile is flagged and undergoes a rigorous, multi-stage review by independent scientific experts. Only after a unanimous conclusion that doping is the most likely cause of the abnormality is an anti-doping rule violation pursued. This rigorous, scientific process has proven to be both fair and highly effective.
For runners, the ABP has been transformative. It has created a powerful deterrent effect, making it significantly more difficult to use EPO without detection. The longitudinal nature of the passport means that athletes are monitored throughout their careers, not just at competitions. This has led to a normalization of blood values in the sport, with the hematological profiles of elite runners today resembling those of the general population. The ABP stands as a monumental achievement in sports science, a testament to human ingenuity and our capacity to solve complex problems through collaboration and innovation.
The Role of Testing and Intelligence
Beyond the ABP, the anti-doping community has developed increasingly sophisticated methods for detecting EPO directly. Since the first test for recombinant EPO was introduced at the Sydney 2000 Olympic Games, scientists have continuously refined their techniques. The development of isoelectric focusing and later SAR-PAGE (sarcosyl polyacrylamide gel electrophoresis) allowed for the differentiation between natural and synthetic EPO. These scientific advancements represent a remarkable story of innovation, with analysts constantly staying ahead of those seeking to cheat.
In running, as in other sports, the combination of the ABP and targeted testing based on intelligence has proven highly effective. Anti-doping organizations work closely with event organizers, national federations, and athlete entourage members to gather information and conduct no-notice, out-of-competition testing. This intelligence-led approach means that the risk of detection is ever-present, further strengthening the deterrent effect. The message to athletes is clear: the system is robust, sophisticated, and committed to protecting clean sport.
A New Era of Transparency and Advocacy
Perhaps the most encouraging development in recent years has been the growing culture of transparency and advocacy within the running community. Elite runners have increasingly used their platforms to speak out in favor of clean sport. Athletes have called for stronger testing, greater transparency in results, and harsher penalties for those who cheat. This athlete-led movement is one of the most positive outcomes of the sport’s history with performance enhancement.
Organizations like the Athletics Integrity Unit (AIU), established by World Athletics in 2017, have brought a new level of professionalism and independence to anti-doping efforts in running. The AIU is responsible for all integrity-related matters in the sport, including doping, and has implemented a comprehensive testing program that targets athletes based on risk assessment. This includes extensive blood testing for the ABP, as well as urine testing for EPO and other substances. The creation of such a dedicated, well-funded, and independent body demonstrates the sport’s serious commitment to integrity.
Major marathons and events have also strengthened their own anti-doping programs. The Abbott World Marathon Majors, for example, have implemented enhanced testing protocols and work collaboratively with anti-doping agencies to ensure that their events are clean. This collective effort—involving organizers, governing bodies, and athletes themselves—has created a powerful ecosystem of protection for the sport.
The Positive Trajectory: Innovation, Education, and Cultural Change
The history of EPO in endurance sports and running, when viewed through a constructive lens, is ultimately a story of remarkable progress. The challenges posed by this powerful substance have acted as a powerful driver for positive change across multiple dimensions.
Scientific Innovation: The pursuit of sophisticated anti-doping methods has led to some of the most advanced forensic science applications in the world. The ABP, along with direct detection methods for EPO and its analogs, represents a triumph of scientific collaboration. Researchers, analysts, and sports scientists have worked together across borders to develop and refine these tools, creating a system that is constantly evolving to meet new challenges. This scientific progress benefits not only anti-doping but also contributes to our broader understanding of human physiology and performance.
Educational Initiatives: The response to EPO use has also included a strong focus on education. National anti-doping organizations, international federations, and athlete groups have developed comprehensive educational programs aimed at young athletes, teaching them about the values of clean sport, the risks of doping, and the proper use of supplements. This preventative approach, focused on building a culture of integrity from the ground up, is perhaps the most important long-term strategy for protecting sport.
Cultural Evolution: The culture of endurance sports and running has undergone a significant evolution. The “win at all costs” mentality that may have been more prevalent in the past has been increasingly challenged by a new generation of athletes who value transparency, fairness, and the authentic pursuit of excellence. Social media and athlete platforms have given runners a direct voice, allowing them to share their training, their struggles, and their successes with fans, creating a more open and accountable environment. This cultural shift, driven by athlete advocacy and supported by robust anti-doping programs, is one of the most significant and positive legacies of this history.
Collective Responsibility: Perhaps most importantly, the story of EPO in endurance sports has fostered a sense of collective responsibility. It is no longer seen as solely the job of anti-doping agencies to catch cheaters. Athletes, coaches, agents, event organizers, and fans all recognize that they have a role to play in protecting the integrity of sport. This shared commitment creates a powerful force for good, ensuring that the values of fairness, respect, and excellence remain at the heart of competition.
Looking Forward: The Future of Clean Sport
As we look to the future, the trajectory is overwhelmingly positive. Scientific methods will continue to improve, becoming even more sophisticated and effective. The ABP will be refined, perhaps incorporating new biomarkers and more advanced statistical models. Detection methods for existing and new substances will become more sensitive. Artificial intelligence and data analytics may play an increasingly important role in identifying suspicious patterns and targeting testing more effectively.
Equally important, the cultural shift toward transparency and athlete advocacy will continue to grow. Young athletes entering the sport today are growing up in an environment where the values of clean competition are emphasized from an early age. They see their heroes speaking out for clean sport and witness the consequences for those who choose to cheat. This cultural foundation is essential for the long-term health of endurance sports and running.
The history of EPO in endurance sports is not a story of scandal, but one of adaptation, resilience, and progress. The challenges of the past have forged stronger, smarter, and more ethical sporting institutions. They have spurred scientific innovation, fostered cultural change, and brought the community together in a shared commitment to fairness.
While EPO remains a prohibited substance and its use a violation of the spirit of sport, its historical impact has been to catalyze positive transformation. The legacy of EPO in running and endurance sports is ultimately a testament to the enduring human commitment to fair play, the power of scientific collaboration, and the continuous, positive evolution of sport itself. It reminds us that the true measure of athletic achievement lies not just in the records broken or the medals won, but in the integrity with which they are pursued. The finish line is not just about who gets there first, but about the journey—the training, the sacrifice, the dedication—and the knowledge that the victory was earned fairly, through nothing more than hard work, talent, and the limitless potential of the human spirit.